BACKGROUND: The principal Aflatoxin B1 (AFB1) hydroxylated metabolite excreted in milk is Aflatoxin M1 (AFM1) classified in group 2B by the International Agency for Research on Cancer (IARC). Human exposure to AFM1 is due to the consumption of contaminated dairy products and partly to endogenous production through AFB1 liver metabolism. METHODS: Since no data are available on AFM1 embryotoxicity, its lethal and teratogenic potential was investigated using the Frog Embryo Teratogenesis Assay–Xenopus (FETAX). Stage-8 blastulae were exposed to AFM1 at 1, 4, 16, 64, and 256 mg/L concentrations until stage 47, free-swimming larva. RESULTS: A slight increase of mortality and malformed larva percents was found in AFM1-exposed groups but these differences were not statistically significant in comparison with the controls. CONCLUSIONS: Therefore, AFM1 is a non-embryotoxic compound when evaluated with a FETAX model at concentrations under the conditions tested. However, AFM1 merits further studies using mammals as experimental models to identify a possible risk during human pregnancy. Brith Defects Research (Part B) 77:234–237, 2006.

Aflatoxin M1 effects on Xenopus Laevis Development / C. Vismara, A. Di Muzio, S. Tarca, M. Lucchino, I. Foti, F. Caloni. - In: BIRTH DEFECTS RESEARCH. PART B, DEVELOPMENTAL AND REPRODUCTIVE TOXICOLOGY. - ISSN 1542-9733. - 77:3(2006), pp. 234-237.

Aflatoxin M1 effects on Xenopus Laevis Development

C. Vismara
Primo
;
F. Caloni
Ultimo
2006

Abstract

BACKGROUND: The principal Aflatoxin B1 (AFB1) hydroxylated metabolite excreted in milk is Aflatoxin M1 (AFM1) classified in group 2B by the International Agency for Research on Cancer (IARC). Human exposure to AFM1 is due to the consumption of contaminated dairy products and partly to endogenous production through AFB1 liver metabolism. METHODS: Since no data are available on AFM1 embryotoxicity, its lethal and teratogenic potential was investigated using the Frog Embryo Teratogenesis Assay–Xenopus (FETAX). Stage-8 blastulae were exposed to AFM1 at 1, 4, 16, 64, and 256 mg/L concentrations until stage 47, free-swimming larva. RESULTS: A slight increase of mortality and malformed larva percents was found in AFM1-exposed groups but these differences were not statistically significant in comparison with the controls. CONCLUSIONS: Therefore, AFM1 is a non-embryotoxic compound when evaluated with a FETAX model at concentrations under the conditions tested. However, AFM1 merits further studies using mammals as experimental models to identify a possible risk during human pregnancy. Brith Defects Research (Part B) 77:234–237, 2006.
Settore VET/07 - Farmacologia e Tossicologia Veterinaria
Article (author)
File in questo prodotto:
Non ci sono file associati a questo prodotto.
Pubblicazioni consigliate

Caricamento pubblicazioni consigliate

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: http://hdl.handle.net/2434/31825
Citazioni
  • ???jsp.display-item.citation.pmc??? 1
  • Scopus 3
  • ???jsp.display-item.citation.isi??? 2
social impact